Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.758 USD | -6.07% | -4.23% | +35.09% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.09% | 31.69M | |
+41.92% | 54.04B | |
+43.57% | 41.96B | |
-1.16% | 41.92B | |
-7.59% | 28.35B | |
+12.16% | 26.35B | |
-22.43% | 19B | |
+7.83% | 13B | |
+28.54% | 12.28B | |
+25.26% | 12.19B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- Viracta's Lymphoma Drug Candidate Granted European Commission's Orphan Drug Designation